698985-06-7 Usage
Uses
Used in Organic Synthesis:
Methyl 4-((2-Methoxy-2-oxoethyl)aMino)-3-nitrobenzoate is used as an intermediate in organic synthesis for the production of various chemical compounds. Its unique structure allows for the formation of different functional groups, making it a versatile building block in the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Pharmaceutical Research:
Methyl 4-((2-Methoxy-2-oxoethyl)aMino)-3-nitrobenzoate is used as a research compound in the development of new pharmaceuticals. Its potential pharmacological properties make it a candidate for further investigation in drug discovery and design. Researchers can use Methyl 4-((2-Methoxy-2-oxoethyl)aMino)-3-nitrobenzoate to explore its biological activity and evaluate its potential as a therapeutic agent.
Used in Environmental and Safety Management:
Due to its potential hazards to human health and the environment, Methyl 4-((2-Methoxy-2-oxoethyl)aMino)-3-nitrobenzoate is used in the development of safety protocols and environmental management strategies. Proper handling, storage, and disposal methods are essential to minimize the risks associated with Methyl 4-((2-Methoxy-2-oxoethyl)aMino)-3-nitrobenzoate and ensure the safety of workers and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 698985-06-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,9,8,9,8 and 5 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 698985-06:
(8*6)+(7*9)+(6*8)+(5*9)+(4*8)+(3*5)+(2*0)+(1*6)=257
257 % 10 = 7
So 698985-06-7 is a valid CAS Registry Number.
698985-06-7Relevant academic research and scientific papers
N-HYDROXYCARBOXAMIDE DERIVATIVES USEFUL AS INHIBITORS OF MAMMALIAN HISTONE DEACETYLASE ACTIVITY
-
Page/Page column 58; 61, (2022/03/09)
A compound of formula (I) or a pharmaceutically acceptable salt thereof. The compound is useful for the treatment of a disorder selected from autoimmune disorders, mental disorders, neurodegenerative disorders, pain, respiratory diseases, and hyperproliferative disorders, in particular cancers.
